Salient Surgical Technologies

Quote






Anonymous said:
Just had my hat handed to me by a doc after looking at our new study! Argh!!!!!! Thanks, Don!
Click to expand...

What did the doc say to you regarding the study?

Did they think the study lacked credibility? Or just question its clinical value economically?

I'd like to know so I can flesh out some answers ahead of time.

Thanks
 






Anonymous said:
What did the doc say to you regarding the study?

Did they think the study lacked credibility? Or just question its clinical value economically?

I'd like to know so I can flesh out some answers ahead of time.

Thanks
Click to expand...

First, he asked why it took 5 years to publish such a small study. Then he pointed out that is a very small study. Then he asked why the allogenic transfusion group had no difference and the only difference was in the autologous group. Do we know?

He also pointed out that none of the endpoints was really clinically unacceptable? and so he did not see the clinical or economic value. He actually also noted the authors own statement regarding the limitations of the study. Argh!!!!!!!!

He also noted Marulanda's and Goldberg's relationship with Salient.

Again, Don thanks! Now I see why you say don't lead with studies. The one we have is crap!
 






It's not a totally hideous study but I can see where it would be met with a, "so...?" Less blood is all well and good but unless that demonstrably (and consistently) translates into improved outcomes / reduction in adverse events / shorter length of stay / faster procedures / cost savings, it's easy to understand why only those who are passionate about blood loss would care.

The disposable is priced much too high. It’s a tough sell without a good body of evidence and that price point is just too much. They’re sacrificing clinical advocacy for margin.
 




































Have seen some various comments about orthopat.here is a brief experience. I had a surgeon interested in aquamantys in addition to the orthopat he was using on his knees and hips. When we tried to do an eval. the product committee shut it down because of the price. Shocker there. What he explained was that after a year orthopat was able to save the hospital 100,000 dollars a year on blood while also reducing the need for predonation. The hospital also had a lot of capital invested in the equipment. Orthopat had service people in the hospital for months during the eval collecting blood data to verify their claims. All I had was a study that does not carry any weight. It is hard to ask them to tack on another 500 to the implant prices and orthopat disposibles
 






Anonymous said:
Have seen some various comments about orthopat.here is a brief experience. I had a surgeon interested in aquamantys in addition to the orthopat he was using on his knees and hips. When we tried to do an eval. the product committee shut it down because of the price. Shocker there. What he explained was that after a year orthopat was able to save the hospital 100,000 dollars a year on blood while also reducing the need for predonation. The hospital also had a lot of capital invested in the equipment. Orthopat had service people in the hospital for months during the eval collecting blood data to verify their claims. All I had was a study that does not carry any weight. It is hard to ask them to tack on another 500 to the implant prices and orthopat disposibles
Click to expand...

when was this? Because the only real study we have just came out. Also, Why not track the data yourself like everyone else does? I call Bullshit and Orthopat rep. lol

Now, the reality is Orthopat is no more cost effective than the AQM.
 












Anonymous said:
Have seen some various comments about orthopat.here is a brief experience. I had a surgeon interested in aquamantys in addition to the orthopat he was using on his knees and hips. When we tried to do an eval. the product committee shut it down because of the price. Shocker there. What he explained was that after a year orthopat was able to save the hospital 100,000 dollars a year on blood while also reducing the need for predonation. The hospital also had a lot of capital invested in the equipment. Orthopat had service people in the hospital for months during the eval collecting blood data to verify their claims. All I had was a study that does not carry any weight. It is hard to ask them to tack on another 500 to the implant prices and orthopat disposibles
Click to expand...

Hey Haemo person who are you talking about Atlantic Health?
 












Anonymous said:
when was this? Because the only real study we have just came out. Also, Why not track the data yourself like everyone else does? I call Bullshit and Orthopat rep. lol

Now, the reality is Orthopat is no more cost effective than the AQM.
Click to expand...

And I should have added, neither really adds any clinical or economic benefit.
 






Anonymous said:
any sales opportunities in NM, AZ, or Vegas? spine rep looking for other sales opportunities.
Click to expand...

Good Lord! If you're any good why in the world would you want to work here. Just because Lynch and Hill's has em eating out of their hands in AZ doesn't mean this product is actually selling anywhere else. Most hospital's are not willing to add $500-$700/case with no solid economic or clinical data. The big users are consultants.

Stay in hardware!
 












don't know cost on plasma surgical but they seem to have a solid solution w/lots of good data.
anyone have figures on the equipment and handpieces? i assume the cap equip number is high
 












Plasma list price is 350 and they will work down to 250. Equipment will be placed for free without the BS PPU programs. Did they get the business after the compairson was complete. Very interesting.
 






Top Bottom
Back
Quote